David Shaw’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

David Shaw’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-706,840	Closed	-$7.05M	–	5498
2022 Q3	$7.05M	Hold	706,840	–	–	0.01%	1713
2022 Q2	$6.98M	Hold	706,840	–	–	0.01%	1756
2022 Q1	$6.94M	Buy	706,840 +198,000	+39%	+$1.94M	0.01%	1963
2021 Q4	$4.96M	Buy	508,840 +408,365	+406%	+$4M	﹤0.01%	2391
2021 Q3	$988K	Buy	100,475 +45,706	+83%	+$446K	﹤0.01%	3606
2021 Q2	$535K	Buy	+54,769	New	+$540K	﹤0.01%	4006

David Shaw's FLAC Position: Q4 2022 in Review

David Shaw sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 706,840 shares — an estimated $7.05M sold.

David Shaw first reported a position in FLAC in Q2 2021 and held it in 6 quarters. The position peaked at $7.05M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

David Shaw reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
David Shaw sold 706,840 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $7.05M.
David Shaw first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
David Shaw's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $7.05M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.